Ascend Wellness Holdings (AAWH) Capital Expenditures Growth (1y) (2021 - 2026)
Ascend Wellness Holdings (AAWH) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.91 Bn | 88.04 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.05 Bn | 20.89 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -21.54% |
| 10 | Ascend Wellness Holdings | 78.95 Mn | 18.03 Mn | 44.88 Mn | 31.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.21% |
| Dec 31, 2025 | -177.92% |
| Sep 30, 2025 | 1,092.05% |
| Jun 30, 2025 | 38,004.35% |
| Mar 31, 2025 | 1,538.17% |
| Dec 31, 2024 | 6,082.14% |
| Sep 30, 2024 | -45.85% |
| Jun 30, 2024 | -100.48% |
| Mar 31, 2024 | -26.52% |
| Dec 31, 2023 | -105.19% |
| Sep 30, 2023 | 268.47% |
| Jun 30, 2023 | 95,400.00% |
| Mar 31, 2023 | -7.08% |
| Dec 31, 2022 | 112.69% |
| Sep 30, 2022 | -100.96% |
| Jun 30, 2022 | 100.04% |
| Mar 31, 2022 | -98.49% |
| Dec 31, 2021 | -355.32% |
| Jun 30, 2021 | -1,152.55% |
| Mar 31, 2021 | 208.83% |